More importantly, Lu et al. revealed a positive correlation between CXCL16 mRNA expression and prostate cancer aggressiveness such that metastatic lesions expressed higher levels of CXCL16 mRNA than the primary prostate tissues [9]. The gene discussed is CXCL16; the disease is prostate carcinoma.